GleamWall
中文EN

STVN Stevanato Group S.p.A. IFRS Annual reports only

Surgical & Medical Instruments & Apparatus · NYSE · SEC CIK 1849853 · Reporting currency EUR

Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY7.4%
TTM net income YoY18.7%
TTM EPS YoY18.6%
Revenue 3-yr CAGR6.4%
Net income 3-yr CAGR-0.7%

Margins

Gross margin29.0%
Operating margin16.8%
Net margin11.8%
FCF margin1.9%
EBITDA margin—

Returns

ROE9.7%
ROA5.7%
ROIC (approx.)11.0%
Asset turnover0.49x

Leverage & solvency

Liabilities / assets41.6%
Debt / equity0.00x
Current ratio1.76x
Interest coverage35.37x

Cash quality & payout

Operating cash flow / net income2.05x
Accruals ratio-6.0%
Payout ratio10.5%
Capex / revenue22.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Annual Quarterly (none) Export CSV 🔒
Unit: EUR FY20252025-12-31FY20242024-12-31
Income statement
Revenue1.19B1.10B
Cost of revenue842.41M801.72M
Gross profit343.88M302.32M
R&D expense25.44M31.67M
SG&A expense99.66M93.75M
Operating income198.80M161.14M
Interest expense5.62M6.11M
Pretax income189.11M160.29M
Income tax49.27M42.52M
Net income139.84M117.78M
EPS (basic)0.510.43
EPS (diluted)0.510.43
Weighted avg. shares (diluted)272.96M271.15M
Balance sheet
Cash & equivalents130.60M98.27M
Receivables302.69M295.95M
Inventory268.25M245.22M
Current assets943.35M880.12M
PP&E, netmay include right-of-use assets (IFRS)1.39B1.25B
Goodwill49.98M49.98M
Intangibles36.87M33.59M
Total assets2.54B2.33B
Current liabilities535.88M477.47M
Total liabilities1.06B924.43M
Shareholders' equity1.49B1.40B
Cash flow statement
Operating cash flow286.08M155.78M
Capital expenditure263.76M302.60M
Free cash flow22.32M-146.82M
Investing cash flow-272.92M-310.21M
Financing cash flow22.06M183.22M
Dividends paid14.74M14.46M

Free plan shows the latest 2 periods; Pro shows all 7 🔒

· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.

· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.

· Amounts are in the company's reporting currency, EUR, not USD; the site does no currency conversion.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.